Has the coronavirus brought chaos to your pharmaceutical supply chain?
Pandemic-induced spot shortages of active pharmaceutical ingredients (APIs) and other materials intensified global supply chain issues, putting additional constraints on a system — and company supply chains — where resources were already limited.
The solution? Focus on your supplier relationships, which are more important than ever.
Take a fresh look at the COVID-affected supply chain — not to mention new and revised ideas about how best to manage the supplier relationship — and you’ll know how to make your suppliers become partners to your success.
Steven Lynn, Executive Vice President of Pharmaceuticals at Regulatory Compliance Associates, Inc. will share the basics of the supplier relationship, emphasizing the best practices you must incorporate to manage it over time.
You’ll come away knowing how to manage problems by tackling them as they arise, conduct pandemic-era supplier audits (how to think about them, prepare for them and execute them) and craft that all-important quality agreement.
- Structure a pharmaceutical supplier agreement that incorporates specific clauses to assist you in monitoring your supplier during the pandemic
- Take advantage of resources limited by COVID-19 within the global supply chain to maintain and/or increase productivity
- Emphasize the basics of the supplier relationship from its beginning, to best practices for managing it over time
- Use new technology to develop best practices for monitoring and overseeing your supplier partnerships
- Conduct world-class supplier audits during the pandemic
- Retain quality oversight in your supplier relationships and deals
Manage your supplier relationships during the pandemic and beyond. You’ll be able to work with them more easily and ensure your products get to market. Join us by registering today.